Story perspectives

Pandemic Disruptions Linked to 17,400 Extra Cancer Deaths

2/5/2026

41 3

Summary

Story summary

A JAMA Oncology study finds cancer patients diagnosed during the early COVID-19 pandemic (2020–2021) had worse short-term survival than those diagnosed 2015–2019.
The study analyzed over 1,000,000 cases and attributes the decline to disruptions in healthcare during the pandemic.
Despite lower overall cancer death rates, short-term survival remained below expectations, contributing to about 17,400 extra deaths, and experts call for further research.

1 of 1

Story summary

A JAMA Oncology study finds cancer patients diagnosed during the early COVID-19 pandemic (2020–2021) had worse short-term survival than those diagnosed 2015–2019.
The study analyzed over 1,000,000 cases and attributes the decline to disruptions in healthcare during the pandemic.
Despite lower overall cancer death rates, short-term survival remained below expectations, contributing to about 17,400 extra deaths, and experts call for further research.